AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Recruitingn/aAges 18 Years - 80 YearsAllHywel Dda Health Board
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye that processes light into a nerve impulse. This leads to damage and blindness via various different mechanisms that are not fully understood. In this study the objective is to recruit people with diabetes and various stages of diabetic eye disease and measure a large number of different chemicals within the blood that might be associated with damage and dysfunction within the retina. Additionally, it will examine the different bacteria within the gut that might affect disease in the eye via chemicals circulating in the blood. This will require participants to have blood samples taken and to provide urine samples. The blood will be analysed with specialised instruments to identify specific molecules circulating wi

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of type 2 diabetes mellitus * Male or female aged 18 - 80 inclusive Exclusion Criteria: * Participant unable or unwilling to consent to inclusion in the study * Prior treatment with intravitreal therapies for DMO * Potential participant with a known infective disease that may put the study team at risk (eg. TB, HIV, hepatitis) * Age 17 yo or less or 81 yo or older * Known underlying genetic condition affecting lipid metabolism
๐Ÿ’Š

What it tests

  • Blood draw for the laboratory assessment
  • Urine sample
๐Ÿ“

Where

1 site
Prince Philip Hospital
Llanelli, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy